R. Evans (Leicester (Leicestershire), United Kingdom), I. Vogiatzis (Blyth, United Kingdom)
Understanding the effectiveness of different aerobic training modalities in COPD: a component network meta-analysis
T. Ward (Leicester, United Kingdom), C. Plumptre (Gloucester, United Kingdom), T. Dolmage (Toronto, Canada), A. Jones (Loughborough, United Kingdom), R. Tretheway (Loughborough, United Kingdom), P. Divall (Leicester, United Kingdom), S. Singh (Leicester, United Kingdom), M. Lindley (Loughborough, United Kingdom), M. Steiner (Leicester, United Kingdom), R. Evans (Leicester, United Kingdom)
|     |
Exercise tolerance and limiting symptoms 5 and 12 months after hospital discharge from COVID-19
M. Baldwin (Leicester, United Kingdom), E. Daynes (Leicester, United Kingdom), U. Karsanji (Leicester, United Kingdom), H. Mcauley (Leicester, United Kingdom), W. Man (London, United Kingdom), R. Evans (Leicester, United Kingdom), S. Singh (Leicester, United Kingdom), P. Hosp-Covid Collaborative Group (Leicester, United Kingdom)
| |
Anxiety and Depression in IPF and response to pulmonary rehabilitation (PR)
G. D Edwards (London, United Kingdom), O. Polgar (Harefield, Uxbridge, United Kingdom), S. Patel (Harefield, Uxbridge, United Kingdom), R. E Barker (Harefield, Uxbridge, United Kingdom), J. Walsh (Harefield, Uxbridge, United Kingdom), J. Harvey (Harefield, Uxbridge, United Kingdom), W. D-C Man (Harefield, Uxbridge, United Kingdom), C. M Nolan (London, United Kingdom)
| |
Improving the well-being in caregivers of patients with COPD using a home-based pulmonary rehabilitation program
S. Gephine (Pérenchies, France), O. Le Rouzic (Lille, France), C. Chenivesse (Lille, France), J. Grosbois (Pérenchies, France)
| |
Quality of ventilation in patients on home NIV included in a telemonitoring programme - TELVENT study
S. Pontier-Marchandise (Toulouse, France), J. Texereau (Paris, France), A. Prigent (Rennes, France), C. Rabec (Dijon, France), J. Gonzalez-Bermejo (Paris, France), F. Gagnadoux (Angers, France), A. Letierce (Morangis, France), J. Winck (Porto, Portugal)
| |
Impact of an online breathing and wellbeing programme (ENO Breathe) in people with persistent symptoms following COVID-19: a randomised controlled trial
K. Philip (London, United Kingdom), H. Owles (London, United Kingdom), S. Mcvey (London, United Kingdom), T. Pagnuco (London, United Kingdom), K. Bruce (London, United Kingdom), H. Brunjes (London, United Kingdom), W. Banya (London, United Kingdom), J. Mollica (London, United Kingdom), A. Lound (London, United Kingdom), S. Zumpe (London, United Kingdom), A. Abrahams (London, United Kingdom), V. Padmanaban (London, United Kingdom), T. Hardy (London, United Kingdom), A. Lewis (London, United Kingdom), S. Elkin (London, United Kingdom), N. Hopkinson (London, United Kingdom)
| |
Reduction of lung hyperinflation improves cardiac preload, contractility, and output in emphysema
M. van der Molen (Groningen, Netherlands), J. Hartman (Groningen, Netherlands), L. Vanfleteren (Gothenborg, Sweden), H. Kerstjens (Groningen, Netherlands), J. Van Melle (Groningen, Netherlands), T. Willems (Groningen, Netherlands), D. Slebos (Groningen, Netherlands)
| |
Feasibility and effectiveness of eccentric training on limb muscle function and functional performance in patients with COPD: a pilot study
S. Pancera (Milan, Italy), N. Lopomo (Brescia, Italy), R. Porta (Milan, Italy), A. Sanniti (Milan, Italy), R. Buraschi (Milan, Italy), L. Bianchi (Milan, Italy)
| |
Surfactant protein-A (SP-A) is a novel marker of lung disorders in patients discharged after COVID-19 pneumonia
O. Shchudro (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine)
| |